Welcome to our dedicated page for Ellington Financial SEC filings (Ticker: EFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ellington Financial Inc. (NYSE: EFC) SEC filings page provides access to the company’s current and historical regulatory disclosures filed with the U.S. Securities and Exchange Commission. Ellington Financial uses Form 8-K filings to report material events such as dividend declarations on its common and preferred stock, announcements of estimated book value per common share as of specific dates, quarterly earnings results, senior unsecured notes offerings, and changes or amendments to equity distribution agreements supporting its at-the-market common stock offering program.
Through these filings, investors can review details about Ellington Financial’s investment activities and capital structure, including information on its Investment Portfolio and Longbridge segments, its issuance of senior unsecured notes due 2030, and the terms of equity distribution agreements with multiple sales agents. The filings also list the company’s securities registered under Section 12(b) of the Exchange Act, including common stock and several series of cumulative redeemable preferred stock traded on the New York Stock Exchange.
On Stock Titan, Ellington Financial filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered tools summarize key points from forms such as 8-K, and help highlight items related to dividends, estimated book value disclosures, financing arrangements, and other reported events. Users can quickly scan filings for information on Ellington Financial’s portfolio strategies, financing transactions, and board actions without reading every line of the underlying documents.
This page is a resource for reviewing Ellington Financial’s official regulatory communications, including exhibits and press releases that are incorporated by reference into its SEC reports.
Ellington Financial Inc. announced on September 8, 2025 that its Board declared a $0.13 monthly dividend on common stock payable October 31, 2025 to holders of record as of September 30, 2025. The company also declared quarterly dividends on four preferred series: $0.624039 per share for Series A (floating rate) payable October 30, 2025; $0.390625 per share for 6.250% Series B payable October 30, 2025; $0.5390625 per share for 8.625% Series C payable October 30, 2025; and $0.4375 per share for 7.00% Series D payable September 30, 2025 to holders of record as of September 20, 2025. A press release dated September 8, 2025 is filed as Exhibit 99.1 and incorporated by reference.
Ellington Financial Inc. furnished a Current Report on Form 8-K to provide a press release announcing its estimated book value per share as of July 31, 2025. The press release dated August 27, 2025 is attached as Exhibit 99.1 and is being furnished under Item 7.01 for Regulation FD purposes. The filing clarifies that the disclosed material is being furnished (not "filed") and therefore is not subject to the liabilities of Section 18 of the Exchange Act and is not incorporated by reference into other filings except by specific reference. The exhibit list also includes the Inline XBRL cover page file as itemized in Item 9.01.
Ellington Financial Inc. reported consolidated assets of $17,071,895 (in thousands) and total liabilities of $15,382,385 as of June 30, 2025, up from $16,317,028 and $14,726,206 at December 31, 2024, respectively. The Company held $211,013 of cash and $19,617 of restricted cash (in thousands) and recorded $14,668,365 in loans, at fair value. Investments in unconsolidated entities increased to $307,722 from $220,078.
For the three months ended June 30, 2025 the Company reported net interest income of $43,343 (in thousands) and total other income (loss) of $49,199. Total expenses were $57,066, producing net income of $51,073 and net income attributable to common stockholders of $42,923. Basic and diluted EPS for the quarter were $0.45 (compared with $0.62 a year earlier). For the six months, net income was $90,397 and EPS was $0.80.
Key balance sheet and financing items include HMBS-related obligations of $9,814,811, repurchase agreements and reverse repurchase activity supporting portfolio financings, and total equity of $1,689,510. The registrant reported 99,893,894 common shares outstanding as of August 8, 2025. (All dollar amounts presented in the filings are expressed in thousands.)